InvestorsHub Logo

kris_kade

12/05/19 6:50 PM

#1344 RE: Bio_pete #1343

May be I am naive but that’s clearly an insider trading - profiting on management decision to offer secondary. But many retails do not know how bad a scumbag GS is.

biotech_researcher

12/06/19 7:16 AM

#1347 RE: Bio_pete #1343

Bio_pete, that appears to be the real world. However, this too shall pass after a few months. The important metric is they now have a slug of cash and can negotiate from strength.